- Home
- CZFS vs NBP Comparison
CZFS vs NBP Comparison
Compare CZFS & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CZFS | NBP |
|---|---|---|
| Founded | 1984 | 2014 |
| Country | United States | United States |
| Employees | N/A | 30 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.7M | 275.2M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | CZFS | NBP |
|---|---|---|
| Price | $63.11 | $1.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 3.2K | ★ 1.1M |
| Earning Date | 04-29-2026 | 04-07-2026 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | ★ 30.26 | N/A |
| EPS | ★ 2.16 | N/A |
| Revenue | ★ $9,881,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.64 | N/A |
| P/E Ratio | $29.22 | ★ N/A |
| Revenue Growth | ★ 2.82 | N/A |
| 52 Week Low | $49.99 | $1.81 |
| 52 Week High | $69.58 | $5.19 |
Technical Indicators
Market Signals| Indicator | CZFS | NBP |
|---|---|---|
| Relative Strength Index (RSI) | 49.07 | 22.10 |
| Support Level | $57.20 | N/A |
| Resistance Level | $69.05 | $2.73 |
| Average True Range (ATR) | 1.78 | 0.15 |
| MACD | -0.22 | -0.04 |
| Stochastic Oscillator | 51.71 | 2.31 |
Price Performance
Historical ComparisonAbout CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.
About NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.